Sanofi ( SNY) and Regeneron’s ( REGN) Dupixent has gained EU approval as the first targeted therapy in more than ten years ...
In this video, Rebecca Saff, MD, PhD, allergy/immunology fellowship director and assistant physician at Massachusetts General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback